ArticleFrontiers in public health2025
Ethical and secure evidence generation from regionwide clinical data through a collaborative environment for advancing predictive care.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Menopause age and hypercholesterolemia comorbidities: a region-wide retrospective cohort study in Andalusia, Spain (2016-2022).BMJ open · 2026Observational
- High-Fidelity Synthetic Data Replicates Clinical Prediction Performance in a Million-Patient Diabetes Cohort.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Redefining pandemic resilience: a roadmap for post-infectious syndrome preparedness and health system transformation.Frontiers in health services · 2026Article
- Advanced maternal age and assisted reproductive technologies: outcomes, genomics, and real-world evidence.Frontiers in reproductive health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ensuring data protection is a major challenge in clinical research involving sensitive patient information. However, secure processing environments (SPEs) enable the ethical and compliant secondary use of real-world data (RWD) for evidence generation. This study presents a collaborative infrastructure integrating a comprehensive Health Population Database (BPS) with a legal and computational framework to facilitate secure, large-scale clinical studies. The Andalusian Platform for Medical Evidence Generation is an SPE embedded within the Andalusian healthcare network, leveraging RWD from over 15 million patients from the BPS. It supports diverse studies, including treatment efficacy, survival analyses, and predictive modeling, while ensuring alignment with the General Data Protection Regulation (GDPR) and proactively designed to meet forthcoming European Health Data Space (EHDS) requirements. Data are processed within a secure ecosystem, preventing unauthorized access and enabling legally compliant research collaborations. By combining clinical RWD with a robust ethical and legal framework, we present a scalable model for secure, data-driven region-level healthcare innovation. The platform supports cost-effective predictive models, particularly relevant for aging populations, and establishes a blueprint for regional and international adaptation. This approach strengthens the role of healthcare systems in both knowledge generation and sustainable economic growth, ensuring that patient data is leveraged for scientific and societal benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.